文献速递妇科

会阴部原发性外阴癌的治疗模式与结局——一项瑞典人群队列研究

Treatment patterns and outcomes in perineal primary vulvar cancer—a population‐based Swedish cohort study
RSS 订阅 · Acta Obstetricia et Gynecologica Scandinavica · 2026-10-26

该研究在两家三级转诊医院纳入2012–2020年571例外阴鳞状细胞癌患者,其中147例(26%)肿瘤位于会阴。53%仅接受手术,23%手术加辅助放疗,24%接受原发放疗;仅手术者2年无进展生存率为82%。

要点

  • 147例会阴部外阴鳞状细胞癌中,53%仅手术,23%手术加辅助放疗,24%原发放疗。
  • 仅手术者2年无进展生存率为82%(95%CI 74–91),辅助放疗为53%,原发放疗为31%。
  • 早期会阴部外阴鳞状细胞癌可通过原发手术成功治疗,晚期最佳策略仍不确定。

核心结论

  • 早期会阴部外阴鳞状细胞癌可通过原发手术成功治疗,晚期的最佳治疗策略仍不确定,需要进一步研究。

研究设计与样本

  • 一项基于人群的研究,在两家三级转诊医院开展,纳入2012–2020年571例原发性外阴鳞状细胞癌女性,其中147例(26%)肿瘤位于会阴;从病历中获取人口学和临床数据,按治疗方式分析生存和并发症。

主要发现

  • 78/147例(53%)仅接受手术,中位切除边缘为5 mm。
  • 34/147例(23%)手术后接受辅助放疗,原因包括淋巴结转移(74%)和/或边缘不足(中位切除边缘1.6 mm)。
  • 35/147例(24%)接受原发放疗。
  • 治疗相关并发症在仅手术者中为47%,辅助放疗后为79%,原发放疗后为71%。
  • 中位随访41个月后,仅手术者疾病进展为3%,辅助放疗后为18%,原发放疗后为33%;2年无进展生存率分别为82%(95%CI 74–91)、53%(95%CI 38–73)和31%(95%CI 19–51)。

关键数值与推荐

  • 仅手术者的2年无进展生存率为82%(95%CI 74–91)。
  • 辅助放疗者的2年无进展生存率为53%(95%CI 38–73)。
  • 原发放疗者的2年无进展生存率为31%(95%CI 19–51)。

临床怎么用

  • 早期会阴部外阴鳞状细胞癌可考虑原发手术治疗,晚期最佳治疗策略仍不确定,需要进一步研究。

局限性

  • 晚期疾病的最佳治疗策略仍不确定,需要进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Perineal vulvar squamous cell carcinoma was identified in 147 of 571 cases. Owing to the anatomical proximity of these tumors to the anus, treatment selection may present considerable clinical challenges. The majority of patients (53%) underwent surgical treatment alone, whereas 23% received surgery combined with adjuvant radiotherapy and 24% were treated with primary radiotherapy. Abstract Introduction The choice of treatment for vulvar squamous cell carcinoma involving the perineum is challenging because of its anatomical proximity to the anus. The study aim was to describe treatment patterns, complications, and survival of women with perineal vulvar squamous cell carcinoma. Material and Methods A population-based study at two tertiary referral hospitals during 2012–2020. Demographic and clinical data were retrieved from medical records. Survival and complications were analyzed according to treatment modality. Relative and progression-free survival were calculated by Kaplan–Meier estimates. Results The cohort comprised 571 women with primary vulvar squamous cell carcinoma, of which 147 (26%) were located at the perineum. Seventy-eight women (78/147; 53%) underwent surgery only with a median resection margin of 5 mm. In 34/147 women (23%), surgery was followed by adjuvant radiotherapy because of lymph node metastasis (74%) and/or insufficient margins (median resection margin 1.6 mm). Primary radiotherapy was delivered to 35/147 women (24%). Treatment-related complications during the first year were recorded in 47% after surgery only, in 79% after adjuvant radiotherapy and in 71% after primary radiotherapy. After a median follow-up of 41 months, disease progression occurred in 3% of women treated with surgery only, in 18% after adjuvant radiotherapy and in 33% after primary radiotherapy. The 2-year progression-free survival was 82% (95% CI, 74–91) after surgery only, 53% (95% CI, 38–73) after adjuvant radiotherapy, and 31% (95% CI, 19–51) after primary radiotherapy. Conclusions When diagnosed at an early-stage, perineal vulvar squamous cell carcinoma can successfully be treated by primary surgery. The optimal treatment strategy for advanced disease remains uncertain and requires further investigation.

来源:Acta Obstetricia et Gynecologica Scandinavica,查看原文。版权归原作者所有。

引用

  1. Acta Obstetricia et Gynecologica Scandinavica:Treatment patterns and outcomes in perineal primary vulvar cancer—a population‐based Swedish cohort study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。